| | 856867-55-5 Basic information More.. |
| Product Name: | Tedizolid Phosphate | | Synonyms: | [(5R)-3-[3-fluoro-4-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl dihydrogen phosphate;Tedizolid phosphate impurity A;(R) -3- (4- (2- (2- methyl-tetrazol-5-yl) pyridin-5-yl) -3-fluorophenyl) -5-hydroxymethyl-oxazolidin-2-one phosphate;(R) -3-(4-(2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyl oxazolidin-2-one phosphate;-3-(4-(2-(2-Methyltetrazol-5-yl)pyridine-5-yl)-3-fluorophenyl)-5-hydroxyMethyl oxazolidin-2-one phosphate;(5R)-3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-[(phosphonooxy)methyl]-2-oxazolidinone;Tedizolid Phosphate (TR-701);Torezolid phosphate | | CAS: | 856867-55-5 | | MF: | C17H16FN6O6P | | MW: | 450.32 | | EINECS: | 1592732-453-0 | | Mol File: | 856867-55-5.mol |  |
Use
Tedizolid phosphate is a new anti-bacterial drug developed by CUBIST PHARMS company. Tedizolid phosphate is a prodrug of Tedizolid. After oral or intravenous administration, Tedizolid phosphate is converted to Tedizolid by phosphatase. Tedizolid is the second generation of oxazolidinone antibiotics, a protein synthesis inhibitors. binding the 50S subunit of bacterial ribosomes, it can inhibit protein synthesis and play a role of antibacterial.
Tedizolid phosphate was approved by the US FDA in June 2014 for treatment of acute bacterial skin and skin structure infections caused by susceptible gram-positive pathogens, including MRSA.
- Tedizolid Phosphate
-
- US $0.00-0.00 / mg
- 2025-01-22
- CAS:856867-55-5
- Min. Order: 10mg
- Purity: 95%+
- Supply Ability: 100000
- Tedizolid phosphate
-
- US $0.00-0.00 / g
- 2025-01-16
- CAS:856867-55-5
- Min. Order: 100g
- Purity: 99%
- Supply Ability: 25kgs
- Tedizolid Phosphate
-
- US $0.00 / g
- 2025-01-13
- CAS:856867-55-5
- Min. Order: 1g
- Purity: More Than 99%
- Supply Ability: 50kg/Month
|
|
856867-55-5
Recommend Suppliers |
|